Year: 2013
Type: other
Source: Neuropsychopharmacology
DOI: 10.1038/npp.2013.213
Authors: Jennifer C Felger, Andrew H Miller
Institutions: Emory University, Winship Cancer Institute
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
Funders: Abbott Laboratories, Pfizer, AstraZeneca, GlaxoSmithKline, Emory University, F. Hoffmann-La Roche, H. Lundbeck A/S, National Institutes of Health, School of Medicine, Emory University, Winship Cancer Institute, National Institute of Mental Health, National Cancer Institute, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: Atlanta Clinical and Translational Science Institute (UL1), Neurobiological and Behavioral Effects of Cytokine Antagonism in Major Depression, G2344886790, Predictors and Targets of Response to Cytokine Antagonism in Depression, G4663421645, Phenotyping Major Depression with Increased Inflammation, Atlanta Clinical and Translational Science Institute (ACTSI) Renewal, Atlanta Clinical and Translational Science Institute (ACTSI) Renewal, G6699147628, G7094225672, G8302275050, Winship Cancer Institute Cancer Center Support Grant
OpenAlex ID: W1966721217
